Author:
Conway Ruairi James Harwood,COOPER William,Smith Natalie,Patole Sonia,Symonds Jenny,Edey Anthony,Maskell Nick A.,Bibby Anna
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference43 articles.
1. Prognostic factors for malignant pleural mesothelioma;F J Brims;Curr Respir Care Rep,2013
2. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma;I Woolhouse;Thorax,2018
3. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;N J Vogelzang;Journal of Clinical Oncology,2003
4. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial;P Baas;Lancet,2021
5. Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, doubleblind, randomised, phase 3 trial;D A Fennell;Lancet Oncol,2021